News & AnalysisCapital Rx gathers $50m Series BCapital Rx, a pharmacy benefit manager, has raised $50 million in Series B financing.ByIris Dorbian3 February 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs